← FDA Drug Approvals (Drugs@FDA)
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2025-12-02
Drug application
- FDA Application #
ANDA202388- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
- Generic name
- SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
- Active ingredients
- METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SANDOZ
- Manufacturer
- Sandoz Inc
- First approval
- 2025-12-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown